MTMR2
Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2
Also known as: CMT4B, KIAA1073, MTMR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13614
- Gene
- MTMR2
- Ensembl
- ENSG00000087053
- Chromosome
- 11
- Canonical length
- 643 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is a member of the myotubularin family of phosphoinositide lipid phosphatases. The encoded protein possesses phosphatase activity towards phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4B, an autosomal recessive demyelinating neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
643 residues, UniProt reviewed canonical sequence.
>Q13614|MTMR2
1 MEKSSSCESL GSQPAAARPP SVDSLSSAST SHSENSVHTK SASVVSSDSI STSADNFSPD
61 LRVLRESNKL AEMEEPPLLP GENIKDMAKD VTYICPFTGA VRGTLTVTNY RLYFKSMERD
121 PPFVLDASLG VINRVEKIGG ASSRGENSYG LETVCKDIRN LRFAHKPEGR TRRSIFENLM
181 KYAFPVSNNL PLFAFEYKEV FPENGWKLYD PLLEYRRQGI PNESWRITKI NERYELCDTY
241 PALLVVPANI PDEELKRVAS FRSRGRIPVL SWIHPESQAT ITRCSQPMVG VSGKRSKEDE
301 KYLQAIMDSN AQSHKIFIFD ARPSVNAVAN KAKGGGYESE DAYQNAELVF LDIHNIHVMR
361 ESLRKLKEIV YPNIEETHWL SNLESTHWLE HIKLILAGAL RIADKVESGK TSVVVHCSDG
421 WDRTAQLTSL AMLMLDGYYR TIRGFEVLVE KEWLSFGHRF QLRVGHGDKN HADADRSPVF
481 LQFIDCVWQM TRQFPTAFEF NEYFLITILD HLYSCLFGTF LCNSEQQRGK ENLPKRTVSL
541 WSYINSQLED FTNPLYGSYS NHVLYPVASM RHLELWVGYY IRWNPRMKPQ EPIHNRYKEL
601 LAKRAELQKK VEELQREISN RSTSSSERAS SPAQCVTPVQ TVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MTMR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- testis: 29 nTPM
- placenta: 23 nTPM
- spinal cord: 20 nTPM
- salivary gland: 19 nTPM
- blood vessel: 17 nTPM
- retina: 17 nTPM
Single-cell type
- oligodendrocytes: 259 nCPM
- late spermatids: 218 nCPM
- cardiomyocytes: 153 nCPM
- lacrimal acinar cells: 140 nCPM
- epicardial cells: 136 nCPM
- late primary spermatocytes: 114 nCPM
Immune cell
- memory CD8 T-cell: 16 nTPM
- NK-cell: 14 nTPM
- MAIT T-cell: 13 nTPM
- gdT-cell: 12 nTPM
- naive CD8 T-cell: 11 nTPM
- basophil: 9.8 nTPM
Brain region
- white matter: 41 nTPM
- basal ganglia: 30 nTPM
- cerebellum: 30 nTPM
- pons: 29 nTPM
- medulla oblongata: 28 nTPM
- cerebral cortex: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MTMR2.
Disease | AllUniProt
Conditions MTMR2 is implicated in, by any mechanism.
- Charcot-Marie-Tooth disease, demyelinating, type 4B1 (CMT4B1) MIM:601382
Disease | GeneticClinVar
61 pathogenic / likely-pathogenic of 676 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Charcot-Marie-Tooth disease type 4B1
- Charcot-Marie-Tooth disease type 4
- Inborn genetic diseases
- Charcot-Marie-Tooth disease
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.22
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dendritic spine maintenance
- myelin assembly
- negative regulation of endocytosis
- negative regulation of excitatory postsynaptic potential
- negative regulation of myelination
- negative regulation of receptor internalization
- neuron development
- phosphatidylinositol biosynthetic process
- phosphatidylinositol dephosphorylation
- positive regulation of early endosome to late endosome transport
- regulation of phosphatidylinositol dephosphorylation
- negative regulation of receptor catabolic process
Molecular functions
- identical protein binding
- phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity
- phosphatidylinositol-3-phosphate phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MTMR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MTMR2 as an antibody target. Whether an autoantibody or antibody against MTMR2 could matter depends on whether native MTMR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MTMR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MTMR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...